NCT00003055View on ClinicalTrials.gov

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1997

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

cisplatin

DRUG

irinotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003055 - Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer | Biotech Hunter | Biotech Hunter